CNGA3 Gene Therapy Study

Product categories:

At the Centre for Ophthalmology, University Hospital Tübingen, gene therapy in achromatopsia is investigated. After a phase 1 trial has proven safety and efficacy in adults, now children will also be treated. Further information: https://www.achromatopsie.de/achromatopsie/gibt-es-eine-therapie/

Exhibitor

Note
The exhibitor is solely responsible for the content of the exhibitor presentation both on the organizer’s website and on the website of the respective exhibitor. The organizer assumes no responsibility or liability whatsoever.

Cookie Consent with Real Cookie Banner